CI Financial Corp. (TSE:CIX – Get Free Report) reached a new 52-week high during trading on Tuesday . The stock traded as high as C$18.39 and last traded at C$18.38, with a volume of 12877 shares. The stock had previously closed at C$18.25.
Analyst Upgrades and Downgrades
A number of analysts have recently issued reports on the stock. TD Securities cut their price target on shares of CI Financial from C$21.00 to C$20.00 and set a “buy” rating for the company in a report on Wednesday, July 17th. Jefferies Financial Group upped their price target on CI Financial from C$19.00 to C$20.00 in a research note on Monday, July 29th. Four analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of C$19.38.
Check Out Our Latest Stock Report on CIX
CI Financial Trading Up 0.5 %
CI Financial (TSE:CIX – Get Free Report) last posted its quarterly earnings results on Thursday, August 8th. The company reported C$0.90 earnings per share (EPS) for the quarter. The company had revenue of C$985.96 million for the quarter. CI Financial had a negative return on equity of 4.48% and a negative net margin of 1.54%. As a group, research analysts expect that CI Financial Corp. will post 4.0092166 earnings per share for the current fiscal year.
CI Financial Company Profile
CI Financial Corp. is a publicly owned asset management holding company. Through its subsidiaries, the firm manages separate client focused equity, fixed income, and alternative investments portfolios. It also manages mutual funds, hedge funds, and fund of funds for its clients through its subsidiaries.
See Also
- Five stocks we like better than CI Financial
- The Most Important Warren Buffett Stock for Investors: His Own
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- Options Trading – Understanding Strike Price
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- Insider Trades May Not Tell You What You Think
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for CI Financial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CI Financial and related companies with MarketBeat.com's FREE daily email newsletter.